‘To
explore the effect of ageing on Cancer Incidence by using world data sets’, by Dr Chris Barnes,
Bangor Scientific and Educational Consultants, email manager@bsec-wales.co.uk
Dr
Barnes’ Homepage Link more cancer and other scientific research at http://drchrisbarnes.co.uk
Abstract
A
comparison is made between the cancers said to be due to aging in the UK as
defined by CRC UK and those in 20 countries worldwide on the basis of
correlation with life expectancy. Bowel
cancer is shown to be the single most prevalent cancer associated with aging
worldwide. Most of the UK cancers of old
age also feature in the worldwide league table but the ranking order is
different. In the UK, these male and female hormonal cancers rank in first
place whereas worldwide they only rank in 9th and 6th
place respectively. Differences in
screening methods, vitamin D status, light at night and the use of Radio
Frequency technologies may potentially
account for the differences. Cervix cancer appears to be negatively correlated
with age. There are two reasons for this. Firstly it is a cancer associated
with a disease vector in sexually
active women and secondly treatment and screening will be poorer in less
developed countries, being generally those with lower life expectancies.
Introduction
It is well known that in
developed countries cancer incidence has been increasing for several
decades. It has been suggested that much
of this increase is simply the product
of ageing.
As the ageing process
proceeds there is said to be more probability of both random and radiation and
carcinogen induced DNA mutations. Further the body’s repair and immune systems do not function as well.
British statistics tend to suggest that some cancers are far more prevalent as a result of ageing than others. According to Cancer Research UK over half (53%) of all cancers are diagnosed in adults aged 50-74 (UK, 2009-2011). However, there are more cases in this group than in the elderly (over 75’s) (in whom rates are higher), because there are more 50-74 year-olds in the population. Slightly more cases are diagnosed in males (an average of 92,902 per year in the UK between 2009 and 2011) than in females (81,794) in this age group.
Prostate cancer accounts for more than a quarter (28%) of cases diagnosed in men aged 50-74 whereas Lung and bowel cancers each contribute 14% of the male total.
Around a third (34%) of cases diagnosed in females aged 50-74 are breast cancers many of which are diagnosed through screening. Lung and bowel cancers account for 12% and 10% of cases, respectively.
Many bowel cancers in this age group will have been detected through bowel screening.
In the over 75 age group , over a third (36%) of all cancers are diagnosed in the elderly (UK, 2009-2011). However, incidence rates peak in the elderly for most cancers, because there are fewer people of this age in the population compared with other age groups . Slightly more cases are diagnosed in males (an average of 60,828 per year in the UK between 2009 and 2011) than in females (57,221).
A quarter (25%) of cancers in elderly men are prostate cancers (Figure 3.2).1-4 Lung and bowel cancers contribute 17% and 15% of cases in this age group, respectively.
Breast (21%), bowel (15%) and lung (15%) cancers are the most common in elderly women.
However
,
Incidence rates for all cancers combined have overall increased for all of the
broad age groups in Great Britain since the mid-1970s.
This suggests that there
may be some factor(s)
at work other than just age. Aging is associated with an affluent
society. Other factors in such affluent
societies may well be associated with cancer in addition to aging.
Hypothesis
If certain cancers are exclusively related to
ageing, it should be possible to compare rates due to aging in Britain
compared to those generated by average data acquired from all over the world as
a result of different countries with differing life expectancies, the range of
life expectancy providing an ‘equivalent age range’.
Method
Linear regressions of the correlations of
cancer incidence rates from 20 countries in the world both developing and
developed nations have been obtained against life expectancy in
those nations. The nations used are ;
Canada, USA, Mexico,
Brazil, Argentina, UK, France, Germany, Poland, Russia,
Saudi Arabia, Turkey, China, Nigeria, South Africa, Indonesia, Japan,
Australia and India.
Data for the
incidence rates in each nation were
taken from the CRC UK website. Life expectancies were taken from http://en.wikipedia.org/wiki/List_of_countries_by_life_expectancy.
The larger the linear
regression factor for each correlation the greater is the relevance of aging
for a particular cancer.
The cancers considered
were: Bladder ,Bowel
,Brain ,Breast ,Cervix ,Kidney. Leukaemia, Lung Liver , Melanoma,
NHL, Oesophagus, Pancreas , Prostate and Stomach.
The range of life
expectancies varied from 53 ( Nigeria) to 86.2 (
Japan).
Results
and Discussion
The
results are tabulated below:
Lung R=.64
In order of rank linked
to aging the cancers are:
Bowel
1st 56%
Pancreas
2nd 50%
Kidney
3rd 44%
Leukaemia
3rd 42%
Lung
+ Brain 4th = 37%
NHL
5TH 36.9%
Breast
6th 25%
Bladder
7th 23.7%
Melanoma
8th 21%
Prostate
9th 20%
Stomach
10th 10%
Oesophagus
11th 2.5%
Liver
12th .04 %
Cervix cancer appears to
be negatively correlated with age. There are two reasons for this. Firstly it
is a cancer associated with a disease vector in sexually active women and secondly treatment and
screening will be poorer in less developed countries, being generally those
with lower life expectancies.
Similarly the last three
cancers on the list also have known disease vectors and are thus also poorly
correlated with age.
Comparison
of World with UK and Discussion.
The most prevalent age
related cancers in the UK are shown diagrammatically below.
Male hormonal cancers are
shown in turquoise and female in pink.
Combining the UK data for
both age ranges and both sexes gives an approximate ranking order: Other;
Prostate/Breast; Bowel; Lung; Bladder, NHL, Uterus, Ovary, Stomach, Pancreas
and Kidney.
Uterus and Ovary have not
been considered in the present study.
Worldwide the cancers
associated with aging would appear to be broadly those in the UK. However, the
ranking order is very different. One possible reason for this is that the UK
may have better screening for breast
and prostate cancer. Another quite
controversial reason is that it has been suggested that X-ray screening methods
for breast cancer may actually initiate a certain number of cancers which
wouldn’t otherwise develop ( refs) .
Other possible reasons
are that in the UK there are factors other than aging which increase cancer
incidence. Extensive use of radio frequency technologies and huge
amounts of light at night may contribute
to a glut of hormonal cancers in the UK.
Furthermore comparison is made here
with several countries which have far more solar UV known to be
protective against cancer because it ensures adequate vitamin D status.
Leukaemia, Brain and
Melanoma cancers feature in the worldwide list of cancers also associated with
aging but not explicitly on the UK list.
Presumably they are lumped in the ‘others’ category.
Further
work
Work is in progress to
identify a common factor which better correlates with cancer the world
over. In the past the present author has
examined factors such as wireless penetration, light at night, solar irradiation
and agricultural chemicals.
A new and surprising
technology related factor which partly correlates life expectancy and yet most
accurately correlates with the incidence of all cancers combined has now been
found by the present author and will be reported upon very shortly.